Company research
CYABRA, INC.
CIK 2032341Updated Nov 12, 2026
CYAB price & chart
Loading TradingView…
NASDAQ:CYAB on TradingView ↗About the company
Cyabra restores trust and authenticity for global enterprises and governments by analyzing actors, behaviors, and content, and translating evidence into clear mitigation steps at scale. When manipulated content, coordinated behaviors, and inauthentic actors distort what’s real online, Cyabra analyzes who is operating, how activity is amplified, and how narratives are leveraged, so teams can act quickly.
In the news
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Submission of Matters to a Vote of Security Holders
Items 1.01, 2.03, 5.07, 9.01
EFFECT filing
DEF 14A filing
S-1 filing
PRE 14A filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
cash flow · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Share-based Payment Arrangement, Noncash Expense | —Source | —Source | —Source | —Source |
| Increase (Decrease) in Accounts Receivable | — | — | —Source | —Source |
| Net Cash Provided by (Used in) Operating Activities | — | — | —Source | —Source |
| Net Cash Provided by (Used in) Investing Activities | — | — | —Source | —Source |
| Payments to Acquire Property, Plant, and Equipment | — | — | —Source | —Source |
| Net Cash Provided by (Used in) Financing Activities | — | — | —Source | —Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | —Source | —Source | —Source | —Source |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | —Source | —Source |
| General and Administrative Expense | —Source | —Source | —Source | —Source |
| Income Tax Expense (Benefit) | —Source | —Source | — | — |
| Net Income (Loss) Attributable to Parent | —Source | —Source | —Source | —Source |
| Net Income (Loss) Available to Common Stockholders, Basic | — | —Source | —Source | —Source |
| Nonoperating Income (Expense) | —Source | —Source | — | — |
income statement · annual statements
| Line item | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 |
|---|---|---|---|---|---|
| Operating Income (Loss)USD | -3,120,000Source | -3,419,000Source | -11,824,000Source | -4,038,000Source | -156,348Source |
| Net Income (Loss) Attributable to ParentUSD | -3,439,000Source | -2,446,000Source | -10,770,000Source | -3,314,000Source | -156,348Source |
| Earnings Per Share, BasicUSD per share | -0.26Source | -1.07Source | -3.1Source | -1.47Source | -156.35Source |
| Earnings Per Share, DilutedUSD per share | -0.26Source | -1.07Source | -3.1Source | -1.47Source | -156.35Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 13,390,609Source | 2,435,385Source | 3,471,031Source | 2,356,837Source | 1,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 13,790,609Source | 2,435,385Source | 3,471,031Source | 2,356,837Source | 1,000Source |
| Additional Financial Items | |||||
| Operating ExpensesUSD | — | — | — | — | 156,348Source |
| Total Revenue | —Source | —Source | —Source | —Source | — |
| Cost of Goods and Services Sold | —Source | —Source | —Source | —Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | —Source | —Source | —Source | —Source | — |
| Income Tax Expense (Benefit) | —Source | —Source | — | — | — |
| General and Administrative Expense | —Source | —Source | —Source | —Source | — |
| Gross Profit | —Source | —Source | —Source | —Source | — |
| InterestExpenseOperating | — | — | —Source | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | —Source | —Source | —Source | — |
| Nonoperating Income (Expense) | —Source | —Source | — | — | — |
| Research and Development Expense | —Source | —Source | —Source | —Source | — |
| Selling and Marketing Expense | —Source | —Source | —Source | —Source | — |
Offerings
Registration 333-299356
Registration 333-297845
Registration 333-293035
Filing attachments
ea029760001ex4-1.htm · 8-K · 2026-07-10
EX-4.1 4 ea029760001ex4-1.htm FORM OF PRE-FUNDED WARRANT Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES A…
Read attachment ↗ea029760001ex4-2.htm · 8-K · 2026-07-10
EX-4.2 5 ea029760001ex4-2.htm FORM OF SERIES A COMMON WARRANT Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURIT…
Read attachment ↗ea029760001ex4-3.htm · 8-K · 2026-07-10
EX-4.3 6 ea029760001ex4-3.htm FORM OF SERIES B COMMON WARRANT Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURIT…
Read attachment ↗ea029760001ex99-1.htm · 8-K · 2026-07-10
EX-99.1 11 ea029760001ex99-1.htm PRESS RELEASE DATED JULY 9, 2026 Exhibit 99.1 Cyabra Announces Pricing of $6.0 Million Private Placement Priced At a Premium to the Market Price with New and Existing Institutional Investors, Management, and Board Members In conjunction with the Private Placement, all outstanding preferred shares will convert into common stock or common stock equivalents in lieu thereof, subject to stockholder approval An existing shareholder, as well as management…
Read attachment ↗ea029544501ex99-1.htm · 8-K · 2026-06-22
EX-99.1 2 ea029544501ex99-1.htm PRESENTATION Exhibit 99.1 Cyabra Nasdaq: CYAB Investor Presentation June 2026 1 Forward Looking Statements This presentation contains forward looking statements that are not historical facts within the meaning of the Private Securities Litigation Reform Act of 1995. Forward looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events a…
Read attachment ↗ea028740302ex99-1_cyabra.htm · 3 · 2026-04-23
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Form 3 (including any and all amendments thereto) with respect to the common stock, par value $0.0001 per share, of Cyabra, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings. The undersigned further agree that each par…
Read attachment ↗